School of Chemistry & Chemical Engineering, Inner Mongolia Key Laboratory of Mongolian Medicinal Chemistry , Inner Mongolia University , 235 West College Road , Hohhot , Inner Mongolia 010020 , P. R. China.
ACS Appl Mater Interfaces. 2018 May 2;10(17):14463-14474. doi: 10.1021/acsami.8b02073. Epub 2018 Apr 19.
6-Amino-6-deoxy-curdlan is a promising nucleic acid carrier that efficiently delivers plasmid DNA as well as short interfering RNA (siRNA) to various cell lines. The highly reactive C6-NH groups of 6-amino-6-deoxy-curdlan prompt conjugation of various side groups including tissue-targeting ligands to enhance cell-type-specific nucleic acid delivery to specific cell lines. Herein, to test the primary-cell-targeting efficiency of the curdlan derivative, we chemically conjugated a macrophage-targeting ligand, mannose, to 6-amino-6-deoxy-curdlan. The resulting curdlan derivative (denoted CMI) readily complexed with siRNA and formed nanoparticles with a diameter of 50-80 nm. The CMI nanoparticles successfully delivered a dye-labeled siRNA to mouse peritoneal macrophages. The delivery efficiency was blocked by mannan, a natural ligand for a macrophage surface mannose receptor (CD206), but not by zymosan, a ligand for the dectin-1 receptor, which is also present on the surface of macrophages. Moreover, CMI nanoparticles were internalized by macrophages only at 37 °C, suggesting that the cellular uptake of CMI nanoparticles was energy-dependent. Furthermore, CMI nanoparticle efficiently delivered siRNA against tumor necrosis factor α (TNFα) to lipopolysaccharide-stimulated primary mouse peritoneal macrophages. In vivo experiments demonstrated that CMI nanoparticles successfully delivered siTNFα to mouse peritoneal macrophages, liver, and lung and induced significant knockdown of the TNFα expression at both messenger RNA and protein levels. Therefore, our design of CMI may be a promising siRNA carrier for targeting CD206-expressing primary cells such as macrophage and dendritic cells.
6-氨基-6-去氧-支链淀粉是一种很有前途的核酸载体,能够有效地将质粒 DNA 以及短干扰 RNA(siRNA)递送至各种细胞系。6-氨基-6-去氧-支链淀粉的高反应性 C6-NH 基团促使与各种侧基(包括组织靶向配体)缀合,以增强对特定细胞系的特定细胞类型的核酸递送。在此,为了测试支链淀粉衍生物对原代细胞的靶向效率,我们将一种巨噬细胞靶向配体(甘露糖)化学连接到 6-氨基-6-去氧-支链淀粉上。所得的支链淀粉衍生物(表示为 CMI)容易与 siRNA 复合,并形成直径为 50-80nm 的纳米颗粒。CMI 纳米颗粒成功地将染料标记的 siRNA 递送至小鼠腹腔巨噬细胞。该递送效率被甘露聚糖(一种巨噬细胞表面甘露糖受体(CD206)的天然配体)阻断,但不受真菌聚糖(一种也存在于巨噬细胞表面的 dectin-1 受体的配体)阻断。此外,CMI 纳米颗粒仅在 37°C 时被巨噬细胞内化,这表明 CMI 纳米颗粒的细胞摄取是能量依赖性的。此外,CMI 纳米颗粒有效地将针对肿瘤坏死因子α(TNFα)的 siRNA 递送至脂多糖刺激的原代小鼠腹腔巨噬细胞。体内实验表明,CMI 纳米颗粒成功地将 siTNFα 递送至小鼠腹腔巨噬细胞、肝脏和肺,并在信使 RNA 和蛋白质水平上诱导 TNFα 表达的显著下调。因此,我们设计的 CMI 可能是一种有前途的 siRNA 载体,可用于靶向表达 CD206 的原代细胞,如巨噬细胞和树突状细胞。